IMMU-19. TARGETING GLIOBLASTOMA IMMUNOSUPPRESSION AND TREATMENT RESISTANCE WITH IBRUTINIB IN COMBINATION WITH STEREOTACTIC RADIATION AND IMMUNE CHECKPOINT BLOCKADE

BACKGROUND: Glioblastoma (GBM) is associated with systemic and intratumoral immunosuppression. Part of this immunosuppression is mediated by myeloid derived suppressor cells (MDSCs). Preclinical evidence shows that ibrutinib, a tyrosine kinase inhibitor FDA approved for use in chronic lymphocytic le...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Ghose, Jayeeta, Raychaudhuri, Baisakhi, Liu, Kevin, Jiang, William, Gulati, Pooja, Liu, Joseph, Rajappa, Prajwal, Ahluwalia, Manmeet, Jacob, Naduparambil, Chakravarti, Arnab, Carson, William, Raval, Raju
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651710/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.449
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados